Kymera Therapeutics, Inc. (KYMR)
77.81
-0.31
(-0.40%)
USD |
NASDAQ |
Dec 31, 16:00
77.72
-0.09
(-0.12%)
After-Hours: 20:00
Kymera Therapeutics Market Cap: 5.598B for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 152.28B |
| Regeneron Pharmaceuticals, Inc. | 81.12B |
| Cytokinetics, Inc. | 7.769B |
| TG Therapeutics, Inc. | 4.733B |
| Protagonist Therapeutics, Inc. | 5.460B |
Market Cap Related Metrics
| PS Ratio | 145.84 |
| PEG Ratio | -0.3971 |
| Price to Book Value | 5.916 |
| Price | 77.81 |
| Earnings Yield | -4.62% |
| PEGY Ratio | -0.3971 |